Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00171288 | Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone | PHASE3 | COMPLETED | 83 | — | — | Aug 1, 2003 | Aug 1, 2005 | Nov 8, 2011 | 1 | Spain |
| Name | Type | Description |
|---|---|---|
| fluvastatin, ezetimibe | DRUG | - |
Inclusion Criteria: * Patients aged 18-75 Primary hypercholesterolemia Signed informed consent Exclusion Criteria: * Patients involved in clinical trials 3 months prior to inclusion Patients treated with drugs specified in protocol Fertile women not using contraceptive methods Other protocol def...